Shah, R., Vojjala, N., Parekh, D., Harisingani, A. R., Dharia, A., Prabhu, R. R., Patan, S., Ahmed, N. (2025). Risk of second primary hematological malignancy post CAR-T cell therapy in relapsed/refractory multiple myeloma: Propensity-matched analysis using TriNetX database.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7523